ALFA INTES

IDROFLOG OPHTHALMIC SOLUTION BASED ON SODIUM HYALURONATE AND SODIUM HYDROCORTISONE PHOSPHATE 15 VIALS OF 0.5 ML

IDROFLOG OPHTHALMIC SOLUTION BASED ON SODIUM HYALURONATE AND SODIUM HYDROCORTISONE PHOSPHATE 15 VIALS OF 0.5 ML

Skip to product information
1 of 1
  • Secure payment
  • Discreet and sanitized package
  • Fast and safe shipping

Description

Descriptive sheet

HYDROFLOG

Description
An ophthalmic solution containing sodium hyaluronate, which, thanks to its mucomimetic and pseudoplastic properties, spreads evenly across the ocular surface, forming a protective viscoelastic bandage. Thus, by exerting a mechanical action ("barrier effect"), IDROFLOG stabilizes the tear film and reduces friction caused by eye movements and blinking. It protects the ocular surface, promoting repair processes following damage to the corneal epithelial cells caused by hyposecretion of the tear film. Indeed, when the glands responsible for secreting the tear film reduce their normal activity—for various reasons—the corneal surface is more exposed to external influences. Over time, these influences cause impaired corneal epithelial cell function, with the associated risk of developing bothersome inflammatory processes. The application of the IDROFLOG bandage allows you to protect the corneal surface from exposure to external insults and, thanks to the ancillary action of Hydrocortisone Sodium Phosphate (a low-dose cortisone agent, low anti-inflammatory power and short duration of action), helps prevent the risk of possible recurrences of inflammatory phenomena.
IDROFLOG is intended for limited use and under the direct supervision of a medical specialist. Finally, IDROFLOG, thanks to its unique saline composition, restores and maintains physiological concentrations of important ions, such as sodium, potassium, and magnesium, essential for the health of the ocular surface. The device contains no preservatives.

Composition
Sodium hyaluronate 2 mg/ml, hydrocortisone sodium phosphate 10 mcg/ml, trisodium citrate, sodium chloride, potassium chloride, magnesium chloride, dibasic sodium phosphate, monobasic sodium phosphate, water for injections.

How to use
IDROFLOG should be dosed individually according to your condition and the recommendations of your ophthalmologist. Generally, instill 1-2 drops of the solution into the conjunctival sac of the eye being treated, 2-4 times a day. The total duration of treatment is 2-6 months but must be specifically established by your ophthalmologist and in any case under his or her direct supervision (follow-up every 30-45 days is recommended).
Detach a single vial from the strip. Remove the top flap by twisting it.
Instill 1-2 drops into the conjunctival sac, letting them fall from above.
IDROFLOG can also be used when wearing contact lenses.

Warnings
When not to use:
- hypersensitivity to the components or other closely related chemical substances;
- in conjunction with viral contamination of the ocular surface, keratitis ulcers, mycosis of the eye, purulent conjunctivitis, purulent and herpetic blepharitis, stye;
- generally contraindicated during pregnancy, breastfeeding and in children.
Due to its viscoelastic properties, the product may cause blurred vision upon instillation. Wait until this effect wears off before driving or using machinery.
IDROFLOG is for external use only.
IDROFLOG should not be used immediately before administering any therapeutic medications, or within twenty minutes of applying any topical drug therapy. If you experience a worsening of eye symptoms during treatment, contact your doctor as soon as possible. Prolonged use may cause side effects; the total duration of treatment should be determined by your ophthalmologist. If an inflammatory process is already underway, your ophthalmologist will decide on the appropriate anti-inflammatory therapy to restore the physiological condition of the ocular surface.
To reduce the risk of contamination during use, it is advisable to open the foil pouch only if the product will be used immediately. Avoid allowing the tip of the vial to come into direct contact with your fingers, eyes, or any other surface.
In rare cases, slight blurring of vision has been observed upon instillation, due to the viscosity of the solution. A slight burning sensation may occur during instillation. This sensation, however, usually subsides. Contact your eye doctor if symptoms persist. Following the instructions in the package leaflet reduces the risk of side effects.
Do not use IDROFLOG after the expiration date indicated on the package. The expiration date applies to unopened and properly stored product.
Keep out of the sight and reach of children.
IDROFLOG must be used under the advice of a medical specialist.

Conservation
Store at a temperature between 2°C and 25°C.

Format
Pack containing 15 vials of 0.5 ml.

ALFA INTES

IDROFLOG OPHTHALMIC SOLUTION BASED ON SODIUM HYALURONATE AND SODIUM HYDROCORTISONE PHOSPHATE 15 VIALS OF 0.5 ML

IDROFLOG OPHTHALMIC SOLUTION BASED ON SODIUM HYALURONATE AND SODIUM HYDROCORTISONE PHOSPHATE 15 VIALS OF 0.5 ML

MINSAN code: 942605066
Previous price: €18,00
Regular price €18,00
Regular price €0,00 Sale price €18,00
-% Sold out
Tax included. Shipping calculated at checkout.
View full details

Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.